首页> 外文期刊>Internal medicine. >Antiretroviral Therapy for Treatment-na?ve Chronic HIV-1 Infection with an Axonal Variant of Guillain-Barré Syndrome Positive for Anti-ganglioside Antibody: A Case Report
【24h】

Antiretroviral Therapy for Treatment-na?ve Chronic HIV-1 Infection with an Axonal Variant of Guillain-Barré Syndrome Positive for Anti-ganglioside Antibody: A Case Report

机译:抗神经节苷脂抗体阳性的格林-巴雷综合征轴突变异体的初治慢性HIV-1感染的抗逆转录病毒疗法:一例报告

获取原文
           

摘要

Guillain-Barré syndrome sometimes manifests as immune reconstitution inflammatory syndrome. We report a treatment-na?ve male with chronic HIV-1 infection who presented with an axonal variant of Guillain-Barré syndrome. Antiretroviral therapy commenced one month later and no rapid improvement or deterioration of tetraparesis was noted. This is the first report that describes the detection and serial measurements of anti-ganglioside antibody in a patient with HIV infection. This case suggests a limited role for T-cell immunity in the production of anti-ganglioside antibody and the pathogenesis of axonal variants, since the antiretroviral therapy-induced improvement in T-cell immunity neither re-elevated anti-ganglioside antibody titer nor worsened tetraparesis.
机译:Guillain-Barré综合征有时表现为免疫重建性炎症综合征。我们报告一位初治男性患有慢性HIV-1感染,表现为Guillain-Barré综合征的轴突变异。一个月后开始抗逆转录病毒疗法,未发现四肢轻瘫的快速改善或恶化。这是第一份描述HIV感染患者抗神经节苷脂抗体检测和系列检测的报告。这种情况表明,T细胞免疫在抗神经节苷脂抗体的产生和轴突变体的发病机理中作用有限,因为抗逆转录病毒疗法诱导的T细胞免疫力的改善既不会使抗神经节苷脂抗体的滴度升高,也不会使四肢瘫痪。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号